Tuesday, June 16, 2020

Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets

Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets The company has received the final approval from the United States Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Deferasirox tablets in the strength of 180 mg, Alembic Pharmaceuticals said in a BSE filing.

from Moneycontrol Business News https://ift.tt/3hwGA2O
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...